Wang, H., Qu, Y., Wang, J., Yao, J., Yang, Z., Shen, L., Ye, X., Fei, C., Xi, M., Xu, M., Ge, J., Zhang, Z., Zhang, Z. (2026). Tegoprazan-based dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a prospective, multicenter, open-label, non-inferiority, randomized controlled trial. Scientific Reports. https://doi.org/10.1038/s41598-026-62237-4